Infectious Diseases

< Back

Overview

The aim of the seven groups of this area is to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group is mainly focused on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new preventive vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. Microbiology studies mechanisms of resistance to antimicrobials, pathogenicity, taxonomy and epidemiology, and infectious diseases diagnostics.

The CRIPS group focuses on the most prevalent aspects of infections in the intensive care unit (ICU), while SODIR group works in the areas of shock, organ dysfunction and resuscitation.

There is also a group focused on infection in immunocompromised pediatric patients, and a group from the CIBBIM-Nanomedicine interested in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of medicine.

Publications

236
total
1,029.655
impact factor
4.363
average impact factor

Director: Ricard Ferrer Roca

During 2017, SODIR has obtained the AGAUR accreditation as an emerging research group.

In collaboration with the Microbiology research group of VHIR, the sepsis research line has consolidated the Sepsis Bank as a support platform for biomedical research in sepsis. This line continues to work with special interest in the identification of biomarkers for the early diagnosis and stratification of patients with sepsis through transcriptomics, metabolomics and proteomics studies, applying systems biology techniques and big data analysis. It also has great interest in early microbiological identification of sepsis using molecular identification techniques that allow the optimization of antimicrobial treatment.

During the year 2017, SODIR has consolidated the Clinical Research Unit as the centralizing unit of all the clinical trials that are carried out in the group, providing a professional and excellent clinical research.

SODIR, through the line of research in lung transplantation, has started a study with competitive funding (Health Institute Carlos III) that aims to analyze the DNA of the donor and its relationship with the pulmonary inflammatory response. It is also important to highlight the studies carried out by the line of research in acute respiratory failure focused on the study of the mechanisms underlying the onset and progression of acute respiratory failure.

VHIR Annual Report 2017